Loss of function mutation of the claudin 16 (CLDN16) gene have been identified as the underlying genetic defect in the majority of patients affected with FHHNC. This evidence concerns the gene CLDN16 and familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis.